NCT06968923

Brief Summary

To verify the non-inferiority, in terms of post-treatment (T1) clinical effectiveness, of a "multidomain" telerehabilitation (TR) protocol compared to conventional outpatient rehabilitation in patients with stroke sequelae, with respect to motor, cognitive, and language functions. The absence of statistically significant differences between the two groups regarding treatment effects for each targeted domain will be considered an indicator of non-inferiority.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P75+ for not_applicable stroke

Timeline
Completed

Started Apr 2018

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 26, 2018

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2025

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

May 5, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 13, 2025

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

May 13, 2025

Status Verified

February 1, 2025

Enrollment Period

7 years

First QC Date

May 5, 2025

Last Update Submit

May 5, 2025

Conditions

Keywords

Stroketelemedicinetelerehabilitationmotorcognitive

Outcome Measures

Primary Outcomes (1)

  • Fugl-Meyer Assessment Upper and Lower Limb (FMA)

    The Fugl-Meyer Assessment (FMA) is a widely used observational scale for evaluating motor recovery in patients with stroke sequelae. In its version focused on the upper and lower limbs, the FMA measures motor control by assessing specific movements of the shoulder, elbow, wrist, hand, hip, knee, and ankle. Each movement is rated on a three-point scale (0 = absent, 1 = partial, 2 = complete). The maximum score is 66 points for the upper limb and 34 for the lower limb, for a total of 100 points in the overall motor function assessment. Higher scores indicate a greater degree of recovery.

    The test is administered at the beginning of the treatment (> six months after the event), after five weeks of treatment, and four weeks post-treatment.

Secondary Outcomes (14)

  • The Trail Making Test - A (TMT-A)

    The test is administered at the beginning of the treatment (> six months after the event), after five weeks of treatment, and four weeks post-treatment.

  • Trail Making Test Part B (TMT-B)

    The test is administered at the beginning of the treatment (> six months after the event), after five weeks of treatment, and four weeks post-treatment.

  • Berg Balance Scale (BBS)

    The test is administered at the beginning of the treatment (> six months after the event), after five weeks of treatment, and four weeks post-treatment.

  • 10 Meters Walking Test (10MWT)

    The test is administered at the beginning of the treatment (> six months after the event), after five weeks of treatment, and four weeks post-treatment.

  • Timed Up and Go (TUG)

    The test is administered at the beginning of the treatment (> six months after the event), after five weeks of treatment, and four weeks post-treatment.

  • +9 more secondary outcomes

Study Arms (2)

Group A

ACTIVE COMPARATOR

The group undergoes a 5-week treatment, twice a week, for a total of 10 rehabilitation sessions. Each session lasts approximately 60 minutes. The treatment follows standard in-person clinical practice.

Group B

EXPERIMENTAL

The group undergoes a 5-week treatment, with 2 hours per week, for a total of 10 hours at home. Each session lasts approximately 20 minutes. The treatment consists of a sequence of exercises performed using the Euleria Home® device, a medical software that enables the delivery of personalized exercise therapy programs designed by a healthcare professional.

Behavioral: Telerehabilitation

Interventions

The group undergoes a 5-week treatment, twice a week, for a total of 10 rehabilitation sessions. Each session lasts approximately 60 minutes. The treatment follows standard in-person clinical practice.

The group undergoes a 5-week treatment, with 2 hours per week, for a total of 10 hours at home. Each session lasts approximately 20 minutes. The treatment consists of a sequence of exercises performed using the Euleria Home® device, a medical software that enables the delivery of personalized exercise therapy programs designed by a healthcare professional.

Group B

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age over 18 years.
  • First diagnosis of ischemic stroke, documented radiologically via CT or MRI scans, corresponding to ICD-9-CM codes 433 and 434 .
  • Presence of aphasia, as assessed by the Aachener Aphasia Test (AAT), and/or cognitive deficits identified through the Oxford Cognitive Screen (OCS).
  • Availability of an ADSL or higher-speed internet connection at the patient's residence.
  • Ability of the patient and/or caregiver to understand and utilize the telerehabilitation system.
  • Provision of written informed consent.

You may not qualify if:

  • Contemporanea partecipazione ad altri studi clinici;
  • Decadimento cognitivo
  • Deformità ossee come conseguenza di precedenti eventi traumatici ai 4 arti;
  • Contratture fisse ai 4 arti valutate come 4/4 alla scala di Ashworth modificata (MAS)
  • Altre patologie neurologiche e ortopediche in grado di interferire con lo studio.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azienda Ospedaliera Universitaria Integrata Verona - UOC di Neuroriabilitazione

Verona, verona, 37134, Italy

RECRUITING

MeSH Terms

Conditions

Stroke

Interventions

Telerehabilitation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesTelemedicineDelivery of Health CarePatient Care ManagementHealth Services Administration

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 5, 2025

First Posted

May 13, 2025

Study Start

April 26, 2018

Primary Completion

April 29, 2025

Study Completion

April 1, 2026

Last Updated

May 13, 2025

Record last verified: 2025-02

Locations